🔎 Trials Near Me

Home › Atherosclerosis › Ohio

Atherosclerosis clinical trials in Ohio

8 studies for Atherosclerosis are looking for participants at sites in Ohio.

Cities in Ohio

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
  • Velocity Clinical Research, Cleveland, Cleveland
  • Centricity Research Columbus Ohio Multispecialty, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Velocity Clinical Research - Cleveland, Beachwood
  • Aultman Hospital, Cardiovascular Consultants, Inc, Canton
  • Velocity Clinical Research - Auburn, Cincinnati
  • and 2 more
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • The Christ Hospital, Cincinnati
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • HNC Dialysis, Ltd., Columbus
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Cincinnati
  • Research Site, Columbus
  • Research Site, Lima
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Pelacarsen Roll-over Extension Program

  • NexGen Research, Lima
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.